Fingerprint
Dive into the research topics of 'Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically